Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab.
Mohamed YI, Lee SS, Demir T, Chamseddine S, Hu ZI, Xiao L, Elsayes K, Morris JS, Wolff RA, Hiatia R, Qayyum A, Rashid A, Duda DG, Yao JC, LaPelusa M, Koay EJ, Mahvash A, Al Azzam A, Dumbrava EE, Hassan M, Amin HM, Kaseb AO.
Mohamed YI, et al. Among authors: demir t.
Cancer Biomark. 2024;41(1):83-91. doi: 10.3233/CBM-230431.
Cancer Biomark. 2024.
PMID: 39269823
Free PMC article.